Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1683 publications
Efficacy of JAK inhibitors in treating dominant dystrophic epidermolysis bullosa and alopecia areata.
Journal: Italian journal of dermatology and venereology
Published: October 03, 2025
Contribution of HMGB1 to Keratinocyte inflammation in Recessive Dystrophic Epidermolysis Bullosa.
Journal: bioRxiv : the preprint server for biology
Published: August 20, 2025
New gene therapies for dystrophic epidermolysis bullosa: progress, promise, and persistent gaps.
Journal: The British journal of dermatology
Published: August 11, 2025
Prademagene Zamikeracel: First Approval.
Journal: Molecular diagnosis & therapy
Published: July 13, 2025
Prademagene zamikeracel (Zevaskyn) for recessive dystrophic epidermolysis bullosa.
Journal: The Medical letter on drugs and therapeutics
Published: July 12, 2025
Off-Label Use of Double-Dose Beremagene Geperpavec (B-VEC) in the Treatment of Recessive Dystrophic Epidermolysis Bullosa: A Promising Clinical Case.
Journal: Pediatric dermatology
Published: July 07, 2025
Rigosertib as a potential therapeutic option for patients with recessive dystrophic epidermolysis bullosa squamous cell carcinoma.
Journal: The British journal of dermatology
Published: June 30, 2025
Safety and Efficacy of Angiotensin Receptor Antagonists in Recessive Dystrophic Epidermolysis Bullosa.
Journal: The Australasian journal of dermatology
Published: June 20, 2025
Last Updated: 10/31/2025